Amgen Inc.
NASDAQ Global SelectTotal Valuation
Amgen Inc. carries a market capitalization of 239.70B, placing it among publicly traded companies globally. Its enterprise value stands at 239.22B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 239.70B |
| Enterprise Value | 239.22B |
Share Statistics
Amgen Inc. currently has 541.00M shares outstanding.
| Shares Outstanding | 541.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Amgen Inc. trades at a trailing price-to-earnings ratio of 22.33. The price-to-sales ratio is 5.13, and the price-to-book ratio stands at 16.76.
| PE Ratio | 22.33 |
| PS Ratio | 5.13 |
| PB Ratio | 16.76 |
| P/TBV Ratio | -7.13 |
| P/FCF Ratio | 13.31 |
| P/OCF Ratio | 15.65 |
Enterprise Valuation
On an enterprise value basis, Amgen Inc. trades at an EV/EBITDA multiple of 14.86 and an EV/FCF ratio of 14.03. The EV/Sales ratio of 6.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.94 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.28 |
| EV / EBITDA | 14.86 |
| EV / EBIT | 20.94 |
| EV / FCF | 14.03 |
Financial Position
Amgen Inc. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 490.28, indicating elevated leverage, while an interest coverage ratio of 6.03 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.37 |
| Quick Ratio | 0.95 |
| Debt / Equity | 490.28 |
| Debt / EBITDA | 3.56 |
| Interest Coverage | 6.03 |
Financial Efficiency
Amgen Inc. posts a return on equity of 91.47 and a return on invested capital of 14.64.
| Return on Equity (ROE) | 91.47 |
| Return on Assets (ROA) | 9.53 |
| Return on Invested Capital (ROIC) | 14.64 |
| Return on Capital Employed (ROCE) | 16.60 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.81 |
Taxes
Over the trailing twelve months, Amgen Inc. has paid 1.54B in income taxes, reflecting an effective tax rate of 15.01.
| Income Tax | 1.54B |
| Effective Tax Rate | 15.01 |
Stock Price Statistics
Amgen Inc.'s stock has gained approximately 56.46292% over the past 52 weeks. The 50-day moving average sits at 393.52, while the 200-day moving average is 357.43.
| Beta (5Y) | N/A |
| 52-Week Price Change | 56.46292% |
| 50-Day Moving Average | 393.52 |
| 200-Day Moving Average | 357.43 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Amgen Inc. generated 38.10B in revenue and converted that into 8.74B in net income, yielding earnings per share of 16.09. EBITDA reached 16.09B, while operating income came in at 11.43B.
| Revenue | 38.10B |
| Gross Profit | 26.48B |
| Operating Income | 11.43B |
| Pretax Income | 10.29B |
| Net Income | 8.74B |
| EBITDA | 16.09B |
| EBIT | 11.43B |
| Earnings Per Share (EPS) | 16.09 |
Balance Sheet
Amgen Inc. holds 13.99B in cash and equivalents against 57.30B in total debt, resulting in a net debt position of 43.32B. Total book value stands at 11.69B, with working capital of 9.46B providing operational flexibility.
| Cash & Cash Equivalents | 13.99B |
| Total Debt | 57.30B |
| Net Debt | 43.32B |
| Equity (Book Value) | 11.69B |
| Book Value Per Share | 21.60 |
| Working Capital | 9.46B |
Cash Flow
Amgen Inc. produced 12.48B in operating cash flow over the past twelve months. After subtracting -2.30B in capital expenditures, free cash flow totaled 10.18B - equivalent to 18.87 per share.
| Operating Cash Flow | 12.48B |
| Capital Expenditures | -2.30B |
| Free Cash Flow | 10.18B |
| FCF Per Share | 18.87 |
Margins
Amgen Inc. operates with a gross margin of 69.52, reflecting its pricing power and cost economics. The operating margin of 29.99 and net profit margin of 22.95 provide insight into operational efficiency.
| Gross Margin | 69.52 |
| Operating Margin | 29.99 |
| Pretax Margin | 27.00 |
| Profit Margin | 22.95 |
| EBITDA Margin | 42.24 |
Dividends & Yields
The company's payout ratio of 60.45 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 9.80 |
| Dividend Yield | N/A |
| Payout Ratio | 60.45 |
| Shareholder Yield | 2.11 |
| FCF Yield | 7.51 |
Stock Splits
Amgen Inc.'s most recent stock split took place on November 22, 1999 with a 1:2 split ratio.
| Last Split Date | 11/22/1999 |
| Split Ratio | 1:2 |
Scores
Amgen Inc. posts an Altman Z-Score of 2.39, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.39 |